Keyphrases
Tayside
100%
Screening Study
100%
Cardiovascular Disease
100%
B-type Natriuretic Peptide
100%
Cardiac Events
100%
Cardiovascular Screening
100%
Whole-body
75%
10-year Risk
50%
Contrast-enhanced MRI
50%
New Biomarkers
50%
Treatment Decisions
25%
Risk Factors
25%
Cholesterol
25%
Coronary Artery Disease
25%
High-density Lipoprotein Cholesterol (HDL-C)
25%
Cardiovascular Outcomes
25%
Record Linkage
25%
Smoking Status
25%
Screening Program
25%
Left Ventricular Function
25%
Risk Prediction
25%
Prospective Cohort Study
25%
Clinical Trial Registry
25%
Angiography
25%
Female Sex
25%
Left Ventricular Mass
25%
MRI Scan
25%
Electronic Records
25%
Novel Biomarkers
25%
Low Heart Rate
25%
Biomarker Testing
25%
Factor Model
25%
Low-intermediate Risk
25%
Cardiac Imaging
25%
Framingham Heart Study
25%
Atheroma Burden
25%
Biomarker Analysis
25%
Preventative Medicine
25%
Delayed Gadolinium Enhancement
25%
Ex-smoking
25%
Medicine and Dentistry
Cardiovascular Risk
100%
Cardiovascular Disease
100%
Brain Natriuretic Peptide
100%
Biological Marker
75%
Magnetic Resonance Imaging
50%
Clinical Trial
25%
Gene Linkage
25%
High-Density Lipoprotein
25%
Cardiovascular System
25%
Ischemic Heart Disease
25%
Prospective Cohort Study
25%
Angiography
25%
Cardiac Imaging
25%
Procaine
25%
Gadolinium
25%
Biochemistry, Genetics and Molecular Biology
Brain Natriuretic Peptide
100%
Magnetic Resonance Imaging
50%
Clinical Trial
25%
Gene Linkage
25%
Cholesterol Blood Level
25%
Prospective Cohort Study
25%
Heart Left Ventricle Mass
25%
Gadolinium
25%
High-Density Lipoprotein
25%